Salofalk^® (mesalazine) and Mesalazine Dr.Falk Pharma are used to treat active UC and maintain patients in remission and are available in 2 oral and 3 rectal formulations:

For oral administration

• Salofalk^® granules – prolonged release formulation available in 3g, 1.5g, 1g and 500mg sachets.
• Salofalk^® tablets – gastro-resistant formulation available as 1g and 500mg tablets (UK only)

For rectal administration:

• Mesalazine Dr Falk Pharma 2 g enema (UK)
• Salofalk® 4g enema (Ireland)
• Salofalk^® 1g rectal foam enema ( UK and Ireland)
• Mesalazine Dr Falk Pharma 500mg suppositories and Salofalk^® 1g suppositories (UK)
• Salofalk^® 250mg and 1g suppositories (Ireland)